Global Tumor-Specific Antigen Market Report 2019: 2017-2018 Data & CAGR Projections Through 2023

DUBLIN, May 30, 2019 /PRNewswire/ --  The "Global Tumor-Specific Antigen Market" report has been added to ResearchAndMarkets.com's offering.

The scope of this report is broad and covers category, source and applications of Tumor-specific Antigen. The market has been segmented by source into coding region and Non-Coding region. Revenue forecasts from 2017 to 2023 are given for each segment and regional market with estimated value derived from the revenue of manufacturers.

The report also includes a discussion of the major players across each region of the Tumor-specific antigen market. Further, it explains the major drivers and regional dynamics of the global Tumor-specific antigen market and current trends within the industry.

The report concludes with a special focus on vendor landscape and includes detailed profiles of the main vendors in the Tumor-specific antigen market.

The Report Includes:

• An overview of the global market for tumor-specific antigen
• Analyses of global market trends, with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
• Coverage of various types of product available in the tumor-specific antigen market and discussion of their potential applications
• Information on oncofetal, oncoviral, overexpressed/accumulated, mutated, lineage restricted and idiotypic tumor-specific antigens and discussion of their specific targets
• Insights into regulatory framework and policies and funding initiatives by the government for cancer research
• A look into advancements in antigen specific T-Cell therapy for cancer and innovation within the industry
• Detailed profiles of the major vendors in the global tumor-specific antigen market including Agilent Technologies Inc., AIVITA Biomedical, Eli Lilly and Co., GO Therapeutics and Merck Millipore

Key Topics Covered:

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• Information Sources
• Methodology
• Geographic Breakdown
• Analyst's Credentials
• Custom Research
• Related Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

• Market Overview
• Market Potential
• Investment Analysis
• Regulatory Framework
• United States
• European Union
• Australia
• Japan
• India
• China
• Industry Growth Drivers
• Surging Demand for Potential Cancer Biomarker Candidates
• Rising Prevalence of Cancer
• Increasing Investments in Cancer Diagnosis and Research
• Rising Focus on Developing Targeted Therapies
• Antigen Specific T-Cell Therapy

Chapter 4 Tumor-specific Antigen Market by Category

• Oncofetal
• Oncoviral
• Overexpressed/Accumulated
• CT9/CT10
• Mutated
• Lineage-Restricted Antigen
• Idiotypic
• Others

Chapter 5 Tumor-specific Antigen Market by Source

• Coding Region
• Non-Coding Region
• Growing the Background of Immunotherapy Targets

Chapter 6 Tumor-specific Antigen Market by Application

• Diagnostics
• Drug Discovery and Development
• Therapeutics
• Risk Assessment
• Prognostics
• Clinical and Basic Research

Chapter 7 Tumor-specific Antigen Market by Region

• North America
• United States
• Canada
• Europe
• United Kingdom
• France
• Germany
• Spain
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• Australia
• Rest of Asia-Pacific
• Rest of the World
• Latin America
• Middle East and Africa

Chapter 8 Tumor-specific Antigen Market Industry Structure

• Industry Structure
• Procurement of Raw Materials
• Manufacturing/Development Process
• End-Users
• Innovation in the Market
• Competitive Analysis

Chapter 9 Company Profiles

• Abcam Plc
• Agilent Technologies Inc.
• Aivita Biomedical
• Bbi Group
• Bio-Rad Laboratories Inc.
• Biomrieux Sa
• Brightpath Biotherapeutics
• Caris Life Sciences Inc.
• Cisbio Bioassays
• Creative Diagnostics
• Eli Lilly And Co.
• Enzo Biochem Inc.
• Externautics
• F. Hoffmann-La Roche Ltd.
• Go Therapeutics
• Janssen Global Services Llc
• Lee Biosolutions Inc.
• Merck Millipore
• Meso Scale Diagnostics, Llc
• Perkinelmer Inc.
• Quest Diagnostics
• Signosis Inc.

For more information about this report visit https://www.researchandmarkets.com/r/m2vl5b

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com